Efficacy and Safety of JMT101 Combined Wth Docetaxel / HB1801 in Patients With Squamous Cell Non-Small Cell Lung Cancer
Conditions: Squamous Cell Non-small Cell Lung Cancer Interventions: Drug: JMT101; Drug: docetaxel; Drug: HB1801 Sponsors: Shanghai JMT-Bio Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Docetaxel | Lung Cancer | Non-Small Cell Lung Cancer | Research | Squamous Cell Carcinoma | Taxotere